Universal Biosensors, Inc. (ASX:UBI) Annual Report 2022



The latest annual report of Universal Biosensors, Inc. (UBI) was published on 31 Dec 2022. An annual report is a document that public corporations must provide annually to shareholders that describes their operations and financial conditions. Typically, an annual report will contain sections such as General corporate information, Operating and Financial highlights, Letter to shareholders from the CEO, Financial statements etc.

Key Statistics - UBI Annual Results

Amounts in AUD

Total Revenue
$4.52M
Gross Profit
$1.59M
EBIT
$-33.01M
Net Tangible Assets
$7.15M
Net Income
$-26.85M
Capital Expenditures
-

UBI Income Statement 2022 Annual Report

As per the latest Income Statement of UBI, the Net revenue increased by - (-) compared to the previous period. The operating income in 2022 increased by - (-). The net income as per the annual report was $-26.85M which decreased by $-16.35M (-156%) compared to previous year.

Income Statement Report (2022/2021)

2022 2021
Total Revenue $4.52M $0.00
Gross Profit $1.59M $1.59M
Operating Income - -
Income Before Tax - -
Net Income $-26.85M $-10.51M

Balance Sheet - UBI 2022 Annual Report

Read further: UBI Balance Sheet Detailed Analysis

The latest balance sheet from annual result of Universal Biosensors, Inc. showed the company increased the cash on balance sheet by $0.00 (0%). The Net tangible assets of UBI on the balance sheet were at $7.15M which is $0.00 (0%) more than previous annual report. The total stockholder equity also increased by - (-) compared to previous reporting period.

Balance Sheet Statement Report (2022/2021)

2022 2021
Cash $2.20M $2.20M
Total Assets - -
Long Term Debt - -
Total Liabilities $3.05M $3.05M
Total Shareholder Equity - -
Net Tangible Assets $7.15M $7.15M

Cash Flow Statement - UBI 2022 Annual Report

The 2022 annual cash flow statement of Universal Biosensors, Inc. showed that the net income decreased by $-16.35M (-156%) compared to previous reporting period. Also the capital expenditure of UBI increased by - (-).

As of 2022, the total cash from investing activities was - and total cash from financing activities was -.

Cash Flow Statement Report (2022/2021)

2022 2021
Net Income $-26.85M $-10.51M
Capital Expenditures - -
Dividends Paid - -
Total Cash From From Investing Activities - -
Total Cash From From Financing Activities - -

Universal Biosensors, Inc. Annual Report History

Income Statement

Income Statement history of Universal Biosensors, Inc. (ASX:UBI)

31 Dec 2022 31 Dec 2021 31 Dec 2014 31 Dec 2013
Total Revenue $4.52M $0.00 $9.53M $15.09M
Cost Of Revenue $0.00 $0.00 $0.00 $0.00
Gross Profit $0.00 $0.00 $0.00 $0.00
Research Development - - - -
Selling General Administrative - - - -
Non Recurring - - - -
Other Operating Expenses - - - -
Total Operating Expenses $0.00 $0.00 $0.00 $0.00
Operating Income - - - -
Total Other Income Expense Net - - - -
Ebit $0.00 $0.00 $0.00 $0.00
Interest Expense - - - -
Income Before Tax - - - -
Income Tax Expense $0.00 $0.00 $0.00 $0.00
Minority Interest - - - -
Net Income From Continuing Ops - - - -
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect Of Accounting Charges - - - -
Other Items - - - -
Net Income $-26.85M $-10.51M $-9.32M $-11.63M
Net Income Applicable To Common Shares - - - -

Balance Sheet Statement

Balance Sheet Statement history of Universal Biosensors, Inc. (ASX:UBI)

31 Dec 2022 31 Dec 2021 31 Dec 2014 31 Dec 2013
Cash $2.20M $2.20M - -
Total Assets - - - -
Total Liab $3.05M $3.05M - -
Long Term Debt - - - -
Total Stockholder Equity - - - -
Net Tangible Assets $7.15M $7.15M - -

Cash Flow Statement

Cash Flow Statement history of Universal Biosensors, Inc. (ASX:UBI)

31 Dec 2022 31 Dec 2021 31 Dec 2014 31 Dec 2013
Net Income $-26.85M $-10.51M - -
Capital Expenditures - - - -
Dividends Paid - - - -
Total Cashflows From Investing Activities - - - -
Total Cash From Financing Activities - - - -